CAS: 1204313-51-8 - Icotinib hydrochloride
- Synonyms:
- Icotinib (Hydrochloride)
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Icotinib (Hydrochloride) REF: IN-DA008TGVCAS: 1204313-51-8 | 99% | To inquire | Thu 02 Jan 25 |
 | Icotinib Hydrochloride REF: 4Z-I-136001CAS: | - - - | To inquire | Tue 07 Jan 25 |
 | Icotinib Hydrochloride REF: TM-T2307CAS: 1204313-51-8 | 99.77% | 60.00 €~495.00 € | Tue 04 Feb 25 |
 | Icotinib Hydrochloride REF: 3D-EYB31351CAS: 1204313-51-8 | Min. 95% | To inquire | Tue 11 Feb 25 |
 | Icotinib Hydrochloride REF: 10-F979653CAS: 1204313-51-8 | 99.84% | - - - | Discontinued product |
Ref: IN-DA008TGV
| 1mg | 150.00 € | ||
| 5mg | 262.00 € | ||
| 10mg | 526.00 € | ||
| 25mg | 642.00 € | ||
| 50mg | To inquire | ||
| 100mg | To inquire | ||
| 200mg | To inquire |
Estimated delivery in United States, on Thursday 2 Jan 2025
Ref: 4Z-I-136001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Icotinib Hydrochloride
CAS:1204313-51-8
Icotinib Hydrochloride, an oral EGFR inhibitor (BPI-2009H), may halt cancer growth by blocking EGFR signaling.
Formula:
C22H22ClN3O4
Purity:
99.77%
Color and Shape:
Solid
Molecular weight:
427.88
Ref: TM-T2307
| 5mg | 60.00 € | ||
| 10mg | 87.00 € | ||
| 25mg | 139.00 € | ||
| 50mg | 225.00 € | ||
| 100mg | 333.00 € | ||
| 200mg | 495.00 € | ||
| 1mL*10mM (DMSO) | 66.00 € |
Estimated delivery in United States, on Tuesday 4 Feb 2025
Icotinib Hydrochloride
CAS:1204313-51-8
Icotinib hydrochloride is a drug that inhibits the activity of several signal pathways in cancer …
Formula:
C22H22ClN3O4
Purity:
Min. 95%
Molecular weight:
427.88 g/mol
Ref: 3D-EYB31351
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 11 Feb 2025
Ref: 10-F979653
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information |
